- Tuesday (3/13): Barclays (LON:BARC) Global Healthcare Conference, Miami (3 days). Cross Country Healthcare (NASDAQ:CCRN); Eli Lilly; Spark Therapeutics (NASDAQ:ONCE); Fresenius Medical Care (NYSE:FMS); AbbVie; Cardinal Health (NYSE:CAH); Hill-Rom Holdings (NYSE:HRC); Mylan (NASDAQ:MYL); Insulet (NASDAQ:PODD); Henry Schein (NASDAQ:HSIC); Wright Medical Group (NASDAQ:WMGI); Exact Sciences (NASDAQ:EXAS); aTyr Pharma (NASDAQ:LIFE); PTC Therapeutics (NASDAQ:PTCT); Varian (NYSE:VAR); Aratana Therapeutics (NASDAQ:PETX); Intellia Therapeutics (NASDAQ:NTLA); CRISPR Therapeutics (NASDAQ:CRSP); Retrophin (NASDAQ:RTRX); Centene (NYSE:CNC); Abbott (NYSE:ABT); Boston Scientific (NYSE:BSX); AMAG Pharmaceuticals (NASDAQ:AMAG); Protagonist Therapeutics (NASDAQ:PTGX); Sangamo Therapeutics (NASDAQ:SGMO); NuVasive (NASDAQ:NUVA); Ironwood Pharmaceuticals (NASDAQ:IRWD); Pacira Pharmaceuticals (NASDAQ:PCRX); Arrowhead Pharmaceuticals (NASDAQ:ARWR); Jazz Pharmaceuticals (NASDAQ:JAZZ); ReWalk Robotics (NASDAQ:RWLK); Syneos Health (NASDAQ:SYNH); Halyard Health (NYSE:HYH); Leap Therapeutics (NASDAQ:LPTX); Masimo (NASDAQ:MASI); Impax Laboratories (NASDAQ:IPXL); Aimmune Therapeutics (NASDAQ:AIMT); bluebird bio (NASDAQ:BLUE); Neurocrine Biosciences (NASDAQ:NBIX); REGENXBIO (NASDAQ:RGNX); Prothena (NASDAQ:PRTA); Clovis Oncology (NASDAQ:CLVS); LabCorp (NYSE:LH); Bristol-Myers Squibb (NYSE:BMY); Mirati Therapeutics (NASDAQ:MRTX); Valeant Pharmaceuticals (NYSE:VRX); Marinus Pharmaceuticals (NASDAQ:MRNS); Ultragenyx (NASDAQ:RARE); Foamix Pharmaceuticals (NASDAQ:FOMX); Luminex (NASDAQ:LMNX); Mazor Robotics (NASDAQ:MZOR); Becton, Dickinson (NYSE:BDX); Tenet Healthcare (NYSE:THC); AmerisourceBergen (NYSE:ABC).
- Now read: AquaBounty Technologies reports FY results
Original article